Oral self-management of palbociclib (Ibrance®) using mobile technology protocol.

ABSTRACT:

Aim

This study will test the feasibility and effectiveness of mobile technology intervention on the patients' self-management of oral anticancer medication. Secondary objectives include acceptability, the usefulness of text messages, and satisfaction by participants and nurses.

Methods

This prospective two-arm study will recruit patients (N = 220) with metastatic breast cancer and initiating treatment with palbociclib (Ibrance ®). Allowing for attrition, patients will be randomized into the control (N = 100) or intervention (N = 100) group. Unidirectional text message reminders will be sent during the treatment cycle through a secure web application using the patient's smartphone. Self-reported survey responses will be collected at three time points; at consent, end of treat

SUBMITTER: Mazzella Ebstein AM 

PROVIDER: S-EPMC8454747 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature